Income Investing Insider
  • Economy
  • Business
  • Investing
  • Stock
No Result
View All Result
  • Economy
  • Business
  • Investing
  • Stock
No Result
View All Result
Income Investing Insider
No Result
View All Result
Home Stock

UnitedHealth stock is historically cheap, but don’t buy it until July 29: here’s why

July 2, 2025
in Stock
UnitedHealth stock is historically cheap, but don’t buy it until July 29: here’s why

UnitedHealth Group Inc (NYSE: UNH) – the largest US health insurer – is trading at a historically attractive valuation at the time of writing.

Despite the apparent bargain, however, famed investor Jim Cramer is urging caution in loading up on UNH shares.

According to the former hedge fund manager, investors should wait for the company’s Q2 earnings on July 29th to decide whether it’s worth owning UnitedHealth stock in the back half of 2025.

UnitedHealth stock may not have bottomed yet

UnitedHealth shares have taken a significant blow in recent months, falling more than 40% year-to-date following a rare earnings miss and a downward revision of full-year guidance.

The quarterly released posted in April marked the insurer’s first to have come in shy of Wall Street estimates since the global financial crisis (2008).

That said, some investors currently see value in UNH stock that’s down nearly 50% versus its all-time high of about $630 in late 2024.

Plus, insider buying has also picked up, with chief executive Stephen Hemsley acquiring 86,000 shares at $288 each – a $25 million vote of confidence.

Still, Jim Cramer isn’t entirely sure the bottom is in yet. “I can’t pound the table,” he said recently on “Mad Money” – referencing the uncertainty surrounding the company’s earnings on July 29th.

“There’s going to be what I think is a clearing event … you may have to pay up 50 points if it turns out this is a good event. But I’m not going to tell you to buy more right now,” he added.

Investors should be patient in buying UNH shares

UnitedHealth’s earnings on July 29th could be a turning point for the NYSE-listed firm.

Investors are hoping for clarity on the company’s earnings trajectory, regulatory headwinds, and the performance of its Optum division, all have which have come under scrutiny.

Cramer’s hesitation reflects broader market skepticism. UNH’s recent disappointment on outlook rattled confidence, especially given its long-standing reputation for operational excellence.

The fact that Mad Money host, once bullish on the stock, is not urging restraints underscores the stakes. For long-term investors, UnitedHealth remains a healthcare powerhouse with a diversified business model and strong cash flow.

But in the short term, the July 29th update could either reignite bullish momentum or deepen the sell-off in UnitedHealth stock. Therefore, patience may be the most prudent strategy until then.

How Wall Street recommends playing UnitedHealth

Despite aforementioned risks and a key event scheduled for July 29th, Wall Street remains at least somewhat bullish on UNH shares at current levels.

According to The Wall Street Journal, the consensus rating on the healthcare stock currently sits at “overweight” with the mean target of about $364, indicating potential upside of about 13% from here.

The post UnitedHealth stock is historically cheap, but don’t buy it until July 29: here’s why appeared first on Invezz

Previous Post

USD/CAD forecast as the US dollar index (DXY) crashes

Next Post

Brazil’s Embraer stock rallies on major SAS aircraft order worth up to $4.6 billion

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Disclaimer: incomeinvestinginsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Recent News

    Nio stock price trapped in a giant descending channel: What’s next?

    Nio stock price trapped in a giant descending channel: What’s next?

    July 3, 2025
    Juniper HPE merger: why Wall Street is bullish on AI-powered networking alliance

    Juniper HPE merger: why Wall Street is bullish on AI-powered networking alliance

    July 3, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Copyright © 2025 incomeinvestinginsider.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Home 1
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Copyright © 2025 incomeinvestinginsider.com | All Rights Reserved